To All Members,
Parenteral Drugs (India) Limited vide its announcement dated January 23, 2024, has informed the Exchange that Hon’ble NCLT, Mumbai Bench, has ordered that the shares of the Company shall automatically stand delisted from all the Stock Exchanges without any cost or liability and the stock exchange shall immediately do the needful to do the delisting.
Further, it may be noted that trading in the shares of the Company is under suspension on account of non-compliance with Regulation 31 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, therefore trading in the shares of the company shall remain suspended till further notice.
Scrip Code
|
Name of the Company
|
524689
|
Parenteral Drugs (India) Limited
|
For further clarification on the above, please email on bse.soplodr@bseindia.com
Manu Thomas
Addl. General Manager-Listing Compliance
|
|
Shyam Bhagirath
Manager-Listing Compliance
|
|